Australia / United States
Every company in the roster headquartered in Australia / United States.
Every company in the roster headquartered in Australia / United States.
1 of 1 companies
| Company | Pipeline | Most advanced | Next readout | Market cap | Cash & inv. | Runway | R&D / yr |
|---|---|---|---|---|---|---|---|
MesoblastMESO · Nasdaq | 2 assets: 1 approved, 1 Ph 3 | rexlemestrocel-LPhase 3 · Heart FailurePartial signal | Jul 2027rexlemestrocel-L · Phase 3 | $1.5B | $122MMar 2026 | ~29.8 qtrs | $35M |
Next readout: the earliest estimated primary completion of a trial the company or a partner on the asset runs (ClinicalTrials.gov). Cash shows its balance-sheet month; runway shows a month only when it comes from an earlier report.